Hospital
Concord Hospital-Franklin
Concord Hospital-Franklin was paid $7.28M by Medicaid between Jan 2018 and Nov 2024, across 93 billing codes. Its largest line is 99283, emergency room visit (moderate) — 31% of everything it billed.
33Billing provider infoCONCORD HOSPITAL-FRANKLIN
FRANKLIN, NH 03235
FRANKLIN, NH 03235
33aNPI1700960895assigned 10/25/2006
33bProvider typeCritical Access Hospital
28Total paid$7.28M
24GClaims121,513
24DCodes billed93
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in New Hampshire
Rank by total paid#3 of 9
Median peer was paid$5.24M
This provider vs. median1.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 35,371 | $1.62M | |
| 2019 | 34,331 | $1.72M | |
| 2020 | 29,635 | $2.01M | |
| 2021 | 9,707 | $662K | |
| 2022 | 9,668 | $1.03M | |
| 2023 | 2,163 | $186K | |
| 2024incomplete | 638 | $61K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 31% | 7,432 | 5,065 | $2.27M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 6,077 | 3,618 | $1.56M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 15% | 3,784 | 2,207 | $1.08M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.7% | 2,851 | 2,137 | $412K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.0% | 834 | 617 | $291K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.7% | 1,269 | 856 | $271K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.7% | 1,530 | 1,036 | $125K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.7% | 2,343 | 1,538 | $122K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.3% | 2,066 | 1,387 | $96K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 3,715 | 2,386 | $94K |
| 71045 | Radiologic examination, chest; single view | <1% | 2,551 | 1,674 | $72K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,480 | 1,755 | $71K |
81 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,779 | $67K |
| J3490 | Unclassified drugs | <1% | 9,005 | $58K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 21 | $46K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,405 | $46K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,416 | $44K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 578 | $38K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,065 | $33K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,097 | $33K |
| 80053 | Comprehensive metabolic panel | <1% | 6,180 | $29K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,735 | $28K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 46 | $27K |
| 80050 | General health panel | <1% | 3,037 | $24K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,025 | $24K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,468 | $24K |
| 96376 | <1% | 437 | $23K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 6,520 | $22K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 73 | $20K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 388 | $20K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 365 | $15K |
| 84484 | <1% | 3,037 | $12K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 34 | $12K |
| 80061 | Lipid panel | <1% | 1,100 | $10K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 425 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 934 | $7K |
| 83690 | <1% | 1,800 | $7K | |
| 87040 | <1% | 1,426 | $7K | |
| 80305 | <1% | 1,450 | $7K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 359 | $7K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 357 | $7K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 694 | $7K |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | <1% | 332 | $7K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,389 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 984 | $5K |
| 83605 | <1% | 1,159 | $5K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,098 | $5K |
| 85610 | <1% | 2,733 | $4K | |
| 82947 | <1% | 1,289 | $4K | |
| 81001 | <1% | 2,589 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 648 | $4K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 602 | $4K |
| 87186 | <1% | 833 | $4K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,457 | $3K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,477 | $3K |
| 83880 | <1% | 220 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 152 | $3K |
| 84703 | <1% | 573 | $3K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 56 | $3K |
| 83735 | <1% | 705 | $3K | |
| 73610 | <1% | 39 | $2K | |
| 87088 | <1% | 871 | $2K | |
| 81025 | <1% | 432 | $2K | |
| J2704 | Injection, propofol, 10 mg | <1% | 75 | $2K |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,532 | $2K |
| 85027 | <1% | 406 | $2K | |
| 85379 | <1% | 284 | $2K | |
| 81003 | <1% | 1,371 | $1K | |
| 87077 | <1% | 249 | $1K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 82 | $1K |
| 99001 | <1% | 165 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 92 | $1K |
| 97162 | <1% | 18 | $889.55 | |
| 86317 | <1% | 82 | $876.60 | |
| 87081 | <1% | 172 | $736.08 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 78 | $678.65 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 77 | $558.59 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 18 | $512.42 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 227 | $493.75 |
| 80074 | <1% | 15 | $473.57 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 138 | $401.52 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 81 | $391.76 |
| 87449 | <1% | 45 | $352.52 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 93 | $206.88 |
| 80076 | <1% | 32 | $197.47 | |
| 86140 | <1% | 33 | $196.45 | |
| 85730 | <1% | 64 | $194.39 | |
| 84439 | <1% | 26 | $132.87 | |
| 82728 | <1% | 12 | $123.22 | |
| 36416 | <1% | 156 | $55.37 | |
| 85652 | <1% | 31 | $46.81 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 17 | $42.66 |
| 87205 | <1% | 16 | $40.93 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSLOANE, SCOTT (CHIEF FINANCIAL OFFICER)
Parent organizationCONCORD HOSPITAL-FRANKLIN
| Provider | Location | Paid |
|---|---|---|
| Concord Hospital, INC. | Concord, NH | $28.77M |
| Concord Hospital-Laconia | Laconia, NH | $9.25M |
| Concord Hospital, INC. | Concord, NH | $3.74M |
| Concord Hospital-Franklin | Franklin, NH | $3.61M |
| Concord Hospital-Laconia | Laconia, NH | $2.92M |
| Concord Hospital-Franklin | Franklin, NH | $2.72M |
| Concord Hospital-Laconia | Laconia, NH | $2.53M |
| Concord Hospital, INC. | Concord, NH | $2.48M |
| Concord Hospital-Laconia | Laconia, NH | $109K |
| Concord Hospital-Laconia | Laconia, NH | $16K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.